Prostate cancer is a significant health concern for men globally, with rising incidence and mortality rates. Early detection ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to consider as you age.

The report provides a detailed analysis of the current marketed drugs and late-stage pipeline drugs.

Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow - and how blocking them could ...

Biocon Ltd's arm, Biocon Biologics Ltd, has received European Commission authorisation for its Vevzuo and Evfraxy biosimilars ...

The rugby club welcomed the Furness Prostate Cancer Support Group on June 28, with coach Paul Crarey putting himself forward ...

A judge has tentatively approved a settlement in a class action lawsuit over patient data at MarinHealth Medical Center. The lawsuit, which was filed last year in Marin County Superior Court, alleges ...

Denosumab biosimilars Vevzuo and Evfraxy are used for treating various bone diseases. The approvals mark a key step in the ...

Increased breast density by itself is not an abnormality as about half of women undergoing mammography will have dense ...

Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, as of July 2, 2025, Pluvicto® (lutetium (177Lu) vipivotide tetraxetan injection) is publicly reimbursed in Quebec for ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...